ZA912588B - Novel alpha-mannosidase and fucosidase inhibitors - Google Patents

Novel alpha-mannosidase and fucosidase inhibitors

Info

Publication number
ZA912588B
ZA912588B ZA912588A ZA912588A ZA912588B ZA 912588 B ZA912588 B ZA 912588B ZA 912588 A ZA912588 A ZA 912588A ZA 912588 A ZA912588 A ZA 912588A ZA 912588 B ZA912588 B ZA 912588B
Authority
ZA
South Africa
Prior art keywords
alpha
mannosidase
novel alpha
fucosidase inhibitors
fucosidase
Prior art date
Application number
ZA912588A
Other languages
English (en)
Inventor
Robert A Farr
A Farr Robert
Norton P Peet
P Peet Norton
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA912588B publication Critical patent/ZA912588B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA912588A 1990-04-12 1991-04-08 Novel alpha-mannosidase and fucosidase inhibitors ZA912588B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50887590A 1990-04-12 1990-04-12

Publications (1)

Publication Number Publication Date
ZA912588B true ZA912588B (en) 1992-01-29

Family

ID=24024437

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912588A ZA912588B (en) 1990-04-12 1991-04-08 Novel alpha-mannosidase and fucosidase inhibitors

Country Status (19)

Country Link
EP (1) EP0451834B1 (enExample)
JP (1) JP2955057B2 (enExample)
KR (1) KR100197382B1 (enExample)
CN (1) CN1033638C (enExample)
AT (1) ATE140692T1 (enExample)
AU (1) AU646855B2 (enExample)
CA (1) CA2040058C (enExample)
DE (1) DE69121000T2 (enExample)
DK (1) DK0451834T3 (enExample)
ES (1) ES2092520T3 (enExample)
FI (1) FI109200B (enExample)
GR (1) GR3020934T3 (enExample)
HU (1) HU213396B (enExample)
IE (1) IE75195B1 (enExample)
IL (1) IL97814A (enExample)
NO (1) NO175856C (enExample)
NZ (1) NZ237734A (enExample)
PT (1) PT97339B (enExample)
ZA (1) ZA912588B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
WO1998014446A1 (en) * 1996-10-01 1998-04-09 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
WO1999021858A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts
KR101784539B1 (ko) * 2010-01-28 2017-10-11 랩터 파마슈티컬스 인코포레이티드 수용체 결합 단백질(ｒａｐ) 펩타이드-푸코시다제 억제제 접합체를 이용한 간 질환의 치료방법
CN101870992A (zh) * 2010-06-21 2010-10-27 天津科技大学 利用基因工程菌耦合发酵合成gdp-岩藻糖的方法
CN102286608B (zh) * 2011-06-08 2014-06-25 郑州安图生物工程股份有限公司 衣原体诊断方法和试剂盒

Also Published As

Publication number Publication date
IE911229A1 (en) 1991-10-23
HU911196D0 (en) 1991-10-28
NZ237734A (en) 1993-05-26
CA2040058A1 (en) 1991-10-13
HUT60994A (en) 1992-11-30
FI109200B (fi) 2002-06-14
IL97814A (en) 1995-08-31
AU7416491A (en) 1991-10-17
NO911419D0 (no) 1991-04-11
FI911751L (fi) 1991-10-13
IE75195B1 (en) 1997-08-27
JP2955057B2 (ja) 1999-10-04
DK0451834T3 (da) 1996-08-26
NO911419L (no) 1991-10-14
GR3020934T3 (en) 1996-12-31
ES2092520T3 (es) 1996-12-01
HU213396B (en) 1997-06-30
DE69121000T2 (de) 1996-12-19
DE69121000D1 (de) 1996-08-29
CA2040058C (en) 2001-10-23
JPH04234834A (ja) 1992-08-24
NO175856C (no) 1994-12-21
FI911751A0 (fi) 1991-04-11
PT97339B (pt) 1998-08-31
EP0451834A2 (en) 1991-10-16
ATE140692T1 (de) 1996-08-15
CN1055732A (zh) 1991-10-30
NO175856B (enExample) 1994-09-12
PT97339A (pt) 1992-01-31
EP0451834A3 (en) 1993-10-20
EP0451834B1 (en) 1996-07-24
CN1033638C (zh) 1996-12-25
KR100197382B1 (ko) 1999-06-15
IL97814A0 (en) 1992-06-21
AU646855B2 (en) 1994-03-10
KR910018341A (ko) 1991-11-30

Similar Documents

Publication Publication Date Title
HU9501151D0 (en) Substituted pyridylpyrazoles
DK0384522T3 (da) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2-thioner
ZA912588B (en) Novel alpha-mannosidase and fucosidase inhibitors
IT1184730B (it) Procedimento per produrre difenilammine oppure n,n'-difenil-fenilendiammine
IT8722888A0 (it) Procedimento per la metilazione dicomposti triazinici contenenti gruppi 2,2,6,6tetrametilpiperidinici.
FI880213A0 (fi) System och foerfarande foer att foelja med vaottemperaturen i en roekgasstroem.
GR81856B (enExample)
IT8721882A0 (it) Apparecchiature per lo scambio di utensili.
FI851142A0 (fi) Superledare med foerbaettrade icke-resis- tiva egenskaper.
EP0641327A4 (en) Novel alpha-mannosidase inhibitors.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
ITMI910319A0 (it) Processo di dealogenazione di 1,3-diossolani
DK0417840T3 (da) Antivirale tetrahydroimidazo(1,4)benzodiazepiner
IT1224306B (it) Procedimento per il post-trattamento di substrati tinti, stampati o foulardati
IT8120307A0 (it) Disposizione per il trattamento termico di pezzi d'opera.
IT8619017A0 (it) Apparecchio per l'incisione di registrazioni.
FI923042A7 (fi) Menetelmä 1b-etyyli-1a-(hydroksimetyyli)-1,2,3,4,6,7,12,12ba-oktahydro -indolo (2,3-a)-kinolitsiinin ja uusien välituotteiden valmistamiseksi
CS471887A1 (en) Cutting extension piece for drilling units' equipment
AR241135A2 (es) "derivados de n-triazinil-n-sulfamoilurea herbicidamente activos y formulacion herbicida que los contiene".
RO91315A2 (ro) Dispozitiv de blocare a sertarelor meselor centralelor telefonice
WO1994012483A3 (de) Thiocyanatomethylthiobenzthiazol-derivate
IT8921649A0 (it) Processo per la riduzione catalistica di composti carbonilici.
IT1228963B (it) Tavolo ad elevata flessibilita' di composizione.
IT8435573U1 (it) Apparecchiatura per l'illuminazione di zone desiderate, localizzate
IT9021936A0 (it) Nuovo modo di apertura scatole per legumi od altro.